CD4 T Cell Responses to the Epstein-Barr Virus are Reduced by Disease-modifying Therapies in Patients with Multiple Sclerosis (P5-1.014)
To investigate the impact of disease-modifying therapies (DMTs) on CD4 T cell responses to Epstein-Barr virus (EBV) antigens in patients with multiple sclerosis (MS).
Authors
- Philippe‐Antoine Bilodeau (ORCID: https://orcid.org/0000-0002-2672-554X)
- Monique Anderson (ORCID: https://orcid.org/0000-0001-7713-2878)
- João Vitor Mahler (ORCID: https://orcid.org/0000-0002-0700-3517)
- Natalia Drosu
- Natasha Bobrowski‐Khoury (ORCID: https://orcid.org/0000-0002-6946-3711)
- Takahisa Mikami (ORCID: https://orcid.org/0000-0003-1851-5259)
- Michael Levy (ORCID: https://orcid.org/0000-0002-7969-8346)
Institutions
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000209101
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00